Hjem › Rhabdomyosarkom › Florida
Rhabdomyosarkom kliniske forsøg i Florida
3 studier for Rhabdomyosarkom søger deltagere på steder i Florida.
Officiel studietekst (engelsk)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- og 2 flere
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- og 4 flere
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT07466316Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 30. jun. 2026 · NCT06625190Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.